Business
ReBuilder Medical Technologies, Inc. (RBRM) to Introduce Popular ReStore® Energy Drink as a Safe & Beneficial Product for Diabetics
ReBuilder Medical Technologies, Inc. (RBRM) to Introduce Popular ReStore® Energy Drink as a Safe & Beneficial Product for Diabetics.
About this update from Cannabiz Mobile Inc
[{"type":"text","content":" Company to use clinical trials to further document product’s value Charles Town, WV – November 23, 2011 - ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) today announced plans to begin recruitment of physicians and subjects for clinical trials of its nutritional supplement, ReStore. The ReStore formula, an all-natural, sugar-free gluten free energy supplement, under license, has been successfully used in the treatment and elimination of sub-clinical depression. One of its unique and unexpected beneficial effects is a marked increase in energy. ReBuilder Medical Technologies, Inc. is marketing ReStore as a nutritional supplement and energy drink that’s both safe and beneficial for diabetics and those suffering from the depressive effects of chronic pain, particularly the symptoms of diabetic peripheral neuropathy. “Diabetics often suffer from vitamin B deficiencies, especially Vitamin B12,” said David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc. “ReStore has a full complement of B vitamins to support the health of diabetic’s nerve cells, and this results in better communication between the brain and the voluntary muscles. By increasing the efficiency of these connections, the patient receives more accurate feedback from his extremities and an increase in muscle fiber recruitment, so that it takes less expenditure of energy to move. All this translates into better mood and more energy.” ReBuilder Medical Technologies, Inc. is best known as a leader in the treatment of diabetic peripheral neuropathy, a devastating condition caused by loss of blood flow to nerve tissue. In addition to causing pain and numbness in the feet and hands, peripheral neuropathy can lead to complete loss of mobility, gangrene, and eventual amputations. In addition, the company has had a strong series of market successes recently, including rapidly advancing sales and the development of several new market segments. Based on proprietary market research estimates, Phillips estimates that 6 percent of this market is available to manufacturers of dietary supplements that hold promise of answering the average diabetic's grossly inconsistent energy levels and resultant depressive episodes. On average, patients spend $833 annually on attempts...